You are here

RIPARIAN PHARMACEUTICALS INC

Company Information
Address
201 DEXTER AVE
WATERTOWN, MA 02472-4228
United States


http://www.riparianpharma.com

Information

UEI: J2DKRSK14FF5

# of Employees: 4


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Pharmacological induction of KLF2 and reversal of endothelial dysfunction for the treatment of hypertension

    Amount: $317,243.00

    PROJECT SUMMARY There is a clear unmet need for new differentiated anti-hypertensive therapies, as high blood pressure and its pathological sequelae remain significant burdens to human health despite ...

    SBIRPhase I2022Department of Health and Human Services National Institutes of Health
  2. Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis

    Amount: $2,804,643.00

    DESCRIPTIONprovided by applicantTherapeutic Reversal of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the worldIn particularatheros ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  3. Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis

    Amount: $538,032.00

    DESCRIPTION (provided by applicant): Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the United States a ...

    STTRPhase I2013Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government